DESFERAL Safety Questions, DESFERAL Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about DESFERAL. Our extensive database of DESFERAL adverse events and DESFERAL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about DESFERAL
DESFERAL Safety Reports
Total DESFERAL reports: 43.DESFERAL FDA safety alerts: No.
Reported deaths: 3 Reported hospitalizations: 12.
Take DESFERAL Side Effects Survey or Share Your DESFERAL Story. DESFERAL Usage.
Physician from GERMANY reported DESFERAL problem on Jan 02, 2007. Male patient was diagnosed with haemosiderosis and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: leukocytosis, platelet count increased. DESFERAL dosage: unknown. During the same period patient was treated with ALLOPURINOL. Patient recovered.
DESFERAL problem was reported by a Physician from FRANCE on Jan 25, 2007. Female patient, 39 years of age, was diagnosed with haemosiderosis, osteoporosis, hypogonadism female and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: autoimmune disorder, rheumatoid arthritis. DESFERAL dosage: 1250 MG, QD. During the same period patient was treated with DIDRONEL, CLIMASTON. Patient recovered.
Physician from UNITED KINGDOM reported DESFERAL problem on Feb 08, 2007. Female patient, 26 years of age, was diagnosed with thalassaemia and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, nuclear magnetic resonance imaging abnormal. DESFERAL dosage: unknown. During the same period patient was treated with EXJADE. Patient recovered.
DESFERAL problem was reported by a Physician from UNITED KINGDOM on Mar 05, 2007. Male patient, 57 years of age, weighting 136.7 lb, was diagnosed with iron overload, myelodysplastic syndrome and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, bone density decreased, high turnover osteopathy, hypophosphataemia, osteopenia, osteoporosis, renal tubular disorder, serum ferritin increased, urine calcium increased. DESFERAL dosage: unknown. During the same period patient was treated with BLOOD AND RELATED PRODUCTS, ASCORBIC ACID. Patient recovered.
Physician from UNITED KINGDOM reported DESFERAL problem on Mar 27, 2007. Female patient, 26 years of age, weighting 141.1 lb, was diagnosed with thalassaemia and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, investigation, nuclear magnetic resonance imaging abnormal, treatment noncompliance. DESFERAL dosage: unknown. During the same period patient was treated with ASCORBIC ACID, PREMPAK C, LEVOTHYROXINE, PENICILLIN V, FOLIC ACID. Patient recovered.
DESFERAL problem was reported by a Physician from TURKEY on Apr 09, 2007. Female patient, 18 years of age, weighting 85.98 lb, was diagnosed with iron overload and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: arrhythmia, cardiac failure. DESFERAL dosage: 50 MG/KG/D. Patient was hospitalized. Patient died on 04/05/2007.
Physician from GERMANY reported DESFERAL problem on Apr 04, 2007. Male patient was diagnosed with haemochromatosis and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: optic neuritis, visual acuity reduced. DESFERAL dosage: unknown. Patient recovered.
DESFERAL problem was reported by a Physician from UNITED KINGDOM on Apr 25, 2007. Male patient, 57 years of age, weighting 136.7 lb, was diagnosed with iron overload, myelodysplastic syndrome and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, bone density decreased, high turnover osteopathy, hypophosphataemia, osteopenia, osteoporosis, renal tubular disorder, serum ferritin increased, urine calcium increased. DESFERAL dosage: unknown. During the same period patient was treated with BLOOD AND RELATED PRODUCTS, ASCORBIC ACID. Patient recovered.
Physician from GERMANY reported DESFERAL problem on May 07, 2007. Male patient, 79 years of age, weighting 196.2 lb, was diagnosed with haemochromatosis and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: optic neuritis, visual acuity reduced. DESFERAL dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, EUTHYROX, ALLOPURINOL, DILTIAZEM. Patient recovered.
DESFERAL problem was reported by a Physician from UNITED STATES on May 02, 2006. Male patient, 14 years of age, was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, lip swelling, pharyngeal oedema, urticaria. DESFERAL dosage: unknown. Patient recovered.
Health Professional from UNITED STATES reported DESFERAL problem on Aug 23, 2006. Male patient, 27 years of age, was diagnosed with iron overload and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: eye disorder, hypoaesthesia facial, mucormycosis, pain, sinusitis, swelling face. DESFERAL dosage: unknown. Patient was hospitalized. Patient recovered.
DESFERAL problem was reported by a Physician from UNITED STATES on Mar 28, 2007. Female patient, 38 years of age, was diagnosed with iron overload and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: copper deficiency, neuropathy. DESFERAL dosage: unknown. During the same period patient was treated with EXJADE, REVLIMID, BLOOD TRANSFUSION, PLATELETS, NEUPOGEN, ARANESP, SYNTHROID, CYMBALTA. Patient recovered.
Physician from reported DESFERAL problem on June 19, 2007. Female patient, 14 years of age, weighting 70.55 lb, was diagnosed with thalassaemia beta and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: hodgkin's disease. DESFERAL dosage: 750 MG/DAY. Patient recovered.
DESFERAL problem was reported by a Physician from GERMANY on June 12, 2006. Female patient was diagnosed with thalassaemia and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: paresis. DESFERAL dosage: unknown. Patient recovered.
Consumer or non-health professional from FRANCE reported DESFERAL problem on Apr 10, 2006. Male patient, 59 years of age, was diagnosed with haemochromatosis, neutropenia and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: aspergillosis, candida sepsis, chills, febrile bone marrow aplasia, haemoglobin decreased, herpes zoster, histiocytosis haematophagic, pancytopenia, platelet count decreased. DESFERAL dosage: unknown. During the same period patient was treated with NEORECORMON, GRANOCYTE. Patient was hospitalized. Patient died.
DESFERAL problem was reported by a Physician from GERMANY on July 07, 2006. Male patient was diagnosed with haemosiderosis and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: leukocytosis, platelet count increased. DESFERAL dosage: unknown. Patient recovered.
Consumer or non-health professional from FRANCE reported DESFERAL problem on Apr 10, 2006. Male patient, 59 years of age, was diagnosed with haemochromatosis, neutropenia and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: aspergillosis, candida sepsis, chills, febrile bone marrow aplasia, haemoglobin decreased, herpes zoster, histiocytosis haematophagic, pancytopenia, platelet count decreased. DESFERAL dosage: unknown. During the same period patient was treated with NEORECORMON, GRANOCYTE. Patient was hospitalized. Patient died.
DESFERAL problem was reported by a Health Professional from NETHERLANDS on July 10, 2006. Male patient, child 11 years of age, was diagnosed with thalassaemia and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: blister, skin disorder, skin inflammation, skin necrosis. DESFERAL dosage: unknown. Patient recovered.
Physician from UNITED STATES reported DESFERAL problem on July 24, 2006. Male patient, 67 years of age, was diagnosed with blood iron increased and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: asthenia, chills, cough, dehydration, dyspnoea, pleuritic pain, pneumonia, pyrexia, renal failure. DESFERAL dosage: unknown. During the same period patient was treated with SYNTHROID. Patient was hospitalized. Patient recovered.
DESFERAL problem was reported by a Physician from UNITED STATES on June 01, 2006. Female patient, 18 years of age, weighting 108.9 lb, was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: restrictive pulmonary disease. DESFERAL dosage: unknown. Patient recovered.
Physician from GERMANY reported DESFERAL problem on Aug 11, 2006. Female patient, 85 years of age, was diagnosed with blood aluminium increased and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: gamma-glutamyltransferase increased, transaminases increased. DESFERAL dosage: unknown. During the same period patient was treated with SEROQUEL, OXAZEPAM, RENAGEL, AXURA. Patient recovered.
DESFERAL problem was reported by a Consumer or non-health professional from SWITZERLAND on Aug 14, 2006. Male patient, 70 years of age, was diagnosed with haemosiderosis and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: cardiac discomfort, dyspnoea, incorrect dose administered, pulmonary oedema, visual acuity reduced. DESFERAL dosage: 3000 MG/D. During the same period patient was treated with EXJADE, CORDARONE, GUTRON. Patient recovered.
Physician from GERMANY reported DESFERAL problem on Aug 11, 2006. Female patient, 85 years of age, was diagnosed with blood aluminium increased and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: gamma-glutamyltransferase increased, transaminases increased. DESFERAL dosage: unknown. During the same period patient was treated with SEROQUEL, OXAZEPAM, RENAGEL, AXURA. Patient recovered.
DESFERAL problem was reported by a Health Professional from ITALY on Sept 05, 2006. Female patient, 33 years of age, was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: neutropenia. DESFERAL dosage: unknown. Patient recovered.
Physician from FRANCE reported DESFERAL problem on July 31, 2006. Female patient, 39 years of age, was diagnosed with haemosiderosis, osteoporosis, hypogonadism female and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: autoimmune disorder, rheumatoid arthritis. DESFERAL dosage: 1250 MG, QD. During the same period patient was treated with DIDRONEL, CLIMASTON. Patient recovered.
DESFERAL problem was reported by a Pharmacist from FRANCE on July 06, 2005. Male patient, child 7 years of age, weighting 62.83 lb, was diagnosed with blood iron increased and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, alanine aminotransferase increased, aplasia pure red cell, bicytopenia, bone marrow failure, bone marrow transplant, c-reactive protein increased, eosinophilia, gamma-glutamyltransferase increased. DESFERAL dosage: 1500 MG MON, WED, FRI ; 2000 MG TUES, THURS. During the same period patient was treated with ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Physician from GERMANY reported DESFERAL problem on Oct 27, 2006. Male patient, 63 years of age, weighting 191.8 lb, was diagnosed with haemosiderosis and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, transaminases increased. DESFERAL dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, CALCIMAGON, FUSID, XIPAMIDE, RENAGEL, ATROVENT, PANTORC, AMBROXOL. Patient recovered.
DESFERAL problem was reported by a Consumer or non-health professional from CANADA on Nov 24, 2006. Male patient, 75 years of age, was diagnosed with iron overload and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. DESFERAL dosage: 200 MG ONCE WEEKLY. Patient recovered.
Consumer or non-health professional from CANADA reported DESFERAL problem on Nov 24, 2006. Male patient, 75 years of age, was diagnosed with iron overload and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. DESFERAL dosage: 200 MG ONCE WEEKLY. Patient recovered.
DESFERAL problem was reported by a Consumer or non-health professional from FRANCE on June 18, 2007. Male patient, 67 years of age, was diagnosed with iron overload, refractory anaemia and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased. DESFERAL dosage: unknown. During the same period patient was treated with RED BLOOD CELLS. Patient recovered.
Health Professional from UNITED KINGDOM reported DESFERAL problem on June 28, 2007. Male patient, child 10 years of age, was diagnosed with thalassaemia beta and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: serum ferritin increased, thrombosis, treatment noncompliance. DESFERAL dosage: unknown. During the same period patient was treated with EXJADE. Patient was hospitalized. Patient recovered.
DESFERAL problem was reported by a Physician from UNITED STATES on July 23, 2007. Female patient, 29 years of age, weighting 143.5 lb, was diagnosed with blood iron increased, dyspepsia, nausea and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, addison's disease, arthralgia, back pain, cellulitis, chest pain, concomitant disease progression, constipation, cough. DESFERAL dosage: 2200 MG, QD. During the same period patient was treated with DESFERAL T, DESFERAL T, DESFERAL T, DESFERAL T, NEXIUM, ZOFRAN, EXJADE. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported DESFERAL problem on July 23, 2007. Female patient, 29 years of age, weighting 143.5 lb, was diagnosed with blood iron increased, dyspepsia, nausea and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, addison's disease, arthralgia, aspartate aminotransferase increased, atelectasis, back pain, cellulitis, chest pain, concomitant disease progression. DESFERAL dosage: 2200 MG, QD. During the same period patient was treated with DESFERAL T, DESFERAL T, DESFERAL T, DESFERAL T, NEXIUM, ZOFRAN, EXJADE. Patient was hospitalized. Patient recovered.
DESFERAL problem was reported by a Pharmacist from CANADA on Aug 01, 2007. Female patient was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: vasculitis. DESFERAL dosage: unknown. Patient recovered.
Pharmacist from CANADA reported DESFERAL problem on Aug 10, 2007. Female patient was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: vasculitis. DESFERAL dosage: unknown. Patient recovered.
DESFERAL problem was reported by a Pharmacist from CANADA on Aug 10, 2007. Female patient was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: vasculitis. DESFERAL dosage: unknown. Patient recovered.
Consumer or non-health professional from JAPAN reported DESFERAL problem on Sept 05, 2007. Female patient, 64 years of age, was diagnosed with haemochromatosis and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. DESFERAL dosage: 1000 MG, UNK. Patient was hospitalized. Patient recovered.
DESFERAL problem was reported by a Physician from UNITED STATES on Sept 05, 2007. Female patient, 29 years of age, weighting 143.5 lb, was diagnosed with blood iron increased, dyspepsia, nausea and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, addison's disease, arthralgia, back pain, cellulitis, chest pain, concomitant disease progression, constipation, cough. DESFERAL dosage: 2200 MG, QD. During the same period patient was treated with NEXIUM, ZOFRAN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported DESFERAL problem on Sept 12, 2007. Female patient, 64 years of age, was diagnosed with haemochromatosis and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, blood glucose increased, glycosylated haemoglobin increased, serum ferritin increased. DESFERAL dosage: 1000 MG, UNK. Patient was hospitalized. Patient recovered.
DESFERAL problem was reported by a Physician from UNITED STATES on Sept 12, 2007. Female patient, child 9 years of age, was diagnosed with blood iron increased and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, osteoporosis, pain, splint application, tenosynovitis. DESFERAL dosage: 750 MG, QD. Patient recovered.
Pharmacist from CANADA reported DESFERAL problem on Sept 17, 2007. Female patient was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: vasculitis. DESFERAL dosage: unknown. Patient recovered.
DESFERAL problem was reported by a Physician from UNITED STATES on Sept 18, 2007. Female patient, child 9 years of age, was diagnosed with blood iron increased and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, osteoporosis, pain, splint application, tenosynovitis. DESFERAL dosage: 750 MG, QD. Patient recovered.
Physician from UNITED STATES reported DESFERAL problem on Sept 18, 2007. Female patient, child 9 years of age, was diagnosed with blood iron increased and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, osteoporosis, pain, splint application, tenosynovitis. DESFERAL dosage: 750 MG, QD. Patient recovered.